Pacira Biosciences, Inc. (PCRX)
22.64
-0.89
(-3.78%)
USD |
NASDAQ |
May 15, 16:00
22.62
-0.02
(-0.07%)
After-Hours: 20:00
Pacira Biosciences EPS Diluted (Quarterly) : 0.0713 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Bristol Myers Squibb Co. | 1.308 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.916M |
| Revenue (Quarterly) | 177.38M |
| Total Expenses (Quarterly) | 174.46M |
| Enterprise Value | 1.100B |
| Gross Profit Margin (Quarterly) | 71.40% |
| Profit Margin (Quarterly) | 1.64% |
| Earnings Yield | 0.55% |
| Operating Earnings Yield | 2.53% |
| Normalized Earnings Yield | 0.6316 |